TSC Alert

Archive for the ‘Clinical Studies’ Topic

PREVeNT Trial Enrolling Participants

The Preventing Epilepsy Using Vigabatrin in Infants with Tuberous Sclerosis Complex (PREVeNT) trial, led by Martina Bebin at the University of Alabama Birmingham, is continuing to enroll participants at seven sites across the country.